Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females
NCT00568126 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2020-08-26
Summary
The purpose of this study is to find out whether Maca Root is effective for treating sexual dysfunction in females that is caused by antidepressant drugs. An additional aim of the study is to document the safety and tolerability of maca root, as well as any potential side effects that it causes.
Conditions
- Antidepressant Induced Sexual Dysfunction
Interventions
- DRUG
-
Maca Root
3g/day of Maca Root for 12 weeks.
- DRUG
-
Placebo provided by research pharmacy daily for 12 weeks.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Center for Complementary and Integrative Health (NCCIH)
collaborator NIH -
A Healthy Alternative, LLC
collaborator OTHER -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Christina Dording, MD · Massachusetts General Hospital
-
David Mischoulon, MD, PhD · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-12-27
- Primary Completion
- 2010-10-05
- Completion
- 2010-10-05
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
NCT01607593 ·Status: COMPLETED
-
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00256113 ·Status: COMPLETED ·Phase: PHASE3
-
Ketamine and Nitroprusside for Depression
NCT03102736 ·Status: COMPLETED ·Phase: PHASE2
-
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00250614 ·Status: COMPLETED ·Phase: PHASE3
-
An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00250627 ·Status: COMPLETED ·Phase: PHASE3
-
KET-RO Plus RO DBT for Treatment Resistant Depression
NCT06138691 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Exercise for Sexual Side Effects of Antidepressants
NCT01189825 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder
NCT00536198 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Deep Anaesthesia With Isoflurane as a Fast-response Antidepressant Agent
NCT04171193 ·Status: UNKNOWN ·Phase: PHASE2
-
Riluzole to Treat Major Depression
NCT00026052 ·Status: COMPLETED ·Phase: PHASE2
-
The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
NCT06827431 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Evaluation of Stress Disorders
NCT00050804 ·Status: COMPLETED ·Phase: PHASE4
-
Trazodone for SSRI-sexual Dsyfunction
NCT01097980 ·Status: COMPLETED ·Phase: NA
-
SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims
NCT00114374 ·Status: TERMINATED ·Phase: PHASE3
-
Open-Label Placebo for the Treatment of Depression
NCT02666989 ·Status: UNKNOWN ·Phase: NA
-
Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder
NCT01454635 ·Status: COMPLETED ·Phase: NA
-
Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.
NCT02981225 ·Status: COMPLETED
-
Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
NCT06860958 ·Status: RECRUITING ·Phase: PHASE3
-
The Nocebo Effect: a Prospective Study of Informed Consent as a Factor in the Prevalence of SSRI's Side Effects
NCT01200615 ·Status: UNKNOWN ·Phase: NA
-
Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
NCT00232167 ·Status: TERMINATED ·Phase: PHASE3
-
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
NCT00048854 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
NCT00705003 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder
NCT04975100 ·Status: COMPLETED ·Phase: PHASE4
-
Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction
NCT00398632 ·Status: TERMINATED ·Phase: PHASE4
-
SSRI Effects on Semen Parameters in Men
NCT00385762 ·Status: COMPLETED